Maternal Health
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
Poland’s Parliamentary Commission Recommends Decriminalization of Abortion
GENEVA, 25.06.2024 – The Center for Reproductive Rights welcomes today’s landmark recommendation by a Polish parliamentary commission in favour of the decriminalization of abortion in Poland. This recommendation signals an important first step in efforts to align Poland’s abortion laws with European and international norms and ensure the health and rights of women and girls […]
Texas Medical Board Fails to Clarify Abortion Ban Exceptions
6.21.2024 (PRESS STATEMENT) — Today, the Texas Medical Board published rules to purportedly clarify exceptions to the state’s harsh abortion bans. The rules were published after undergoing a 30-day public comment period and a public hearing, during which numerous physicians and concerned citizens– including Kate Cox and multiple plaintiffs in Zurawski v. Texas – spoke […]
![Rally at south carolina legislature](https://reproductiverights.org/wp-content/uploads/2022/12/Rally-South-Carolina-State-Legislature-cropped-750x422.jpeg)
Abortion on the Ballot
Since the U.S. Supreme Court eliminated the constitutional right to abortion, voters have come out and shown strong support for reproductive freedom. Voters in more states will get to weigh in this November.
![](https://reproductiverights.org/wp-content/uploads/2024/06/Nancy-ABC-FDA-ruling-6-13-24_v2-750x422.png)
Media Highlights: Supreme Court Ruling in Alliance for Hippocratic Medicine v. FDA
The United States Supreme Court ruled June 13 that the plaintiffs suing the Food and Drug Administration (FDA) in Alliance for Hippocratic Medicine v. FDA did not have standing to bring the case, leaving access to the popular abortion medication mifepristone unchanged. Below are media highlights about the ruling.
![medication abortion](https://reproductiverights.org/wp-content/uploads/2023/03/lightbox-abortion-medication-750x422.jpg)
Access to Abortion Medication Remains Unchanged After Ruling by the U.S. Supreme Court
Court rules that anti-abortion plaintiffs suing the FDA do not have standing, leaving the widely used abortion drug accessible through telemedicine and pharmacies—for now.
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
Supreme Court Ruling Maintains Access to Mifepristone
Current regulations of mifepristone will remain unchanged for now
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
U.S. Supreme Court Ruling: Alliance for Hippocratic Medicine v. FDA
![Amanda Zurawski Molly Duane instagram reels 2](https://reproductiverights.org/wp-content/uploads/2024/06/Amanda-Zurawski-Molly-Duane-instagram-reels-2-750x422.png)
Reactions to the Zurawski Ruling: Molly Duane and Amanda Zurawski
“Frankly, this ruling feels like a gut punch, not just for pregnant Texans but also for doctors in our state.” —Lead plaintiff Amanda Zurawski
![Zurawski plaintiffs and Molly Duane outside the Texas Supreme Court, 11-28-23](https://reproductiverights.org/wp-content/uploads/2023/12/Zurawski-plaintiffs-1B1A9880-scaled-aspect-ratio-16-9-750x422.jpg)
News Coverage: Texas Supreme Court Ruling
Media coverage on the Texas Supreme Court’s May 31 ruling in Zurawski v. Texas.